Document is current
Any future updates will be listed below
-
Authors
Gerlach, Andrew R. https://orcid.org/0000-0002-4022-1356
Karim, Helmet T.
Kolobaric, Antonija
Boyd, Brian D.
Kahru, Kevin
Krafty, Robert T.
Ajilore, Olusola https://orcid.org/0000-0003-0737-0437
Taylor, Warren D.
Andreescu, Carmen https://orcid.org/0000-0003-3767-5127
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01 MH133913, K01 MH122741, R01 MH121619, R01 MH121384, R01 MH121620, R01 MH121619, R01 MH108509)
- License Information
-
More Information
Article History
Received: 5 March 2025
Revised: 1 May 2025
Accepted: 15 May 2025
First Online: 29 May 2025
Competing interests
: OA is a co-founder of Keywise AI, has served as a consultant for Sage Therapeutics and Otsuka, has received honoraria from Boehringer Ingelheim, and is on the advisory board for Blueprint Health and Embodied Labs. AK serves as a consultant for Radicle Science. No other authors have disclosures to report.
